Jie Jin

机构：Guizhou Normal University, Sun Yat-sen University, Second Military Medical University, Chinese PLA General Hospital, Maria Fertility Hospital, Zhejiang Lab, Zhejiang Center for Disease Control and Prevention, The First People's Hospital of Wenling, Sun Yat-sen University Cancer Center, Second Affiliated Hospital of Zhejiang University, First Affiliated Hospital Zhejiang University, Zhejiang University of Technology, Zhejiang University · ORCID：0000-0003-4617-2601

发表论文 167 篇 · 总被引 2837 次 · h-index 28

代表论文

• Epcoritamab, lenalidomide, and rituximab versus lenalidomide and rituximab for relapsed or refractory follicular lymphoma (EPCORE FL-1): a global, open-label, randomised, phase 3 trial (2025 · The Lancet · 被引 19)
• Flexible Temperature Sensor with Wide Sensing Range and Fast Response Enabled by PEDOT:PSS/CNT and Thermal Management Encapsulation (2025 · ACS Applied Electronic Materials · 被引 12)
• Further validating of the Depression Anxiety Stress Scales-21 (Dass-21) in Chinese adolescents: factor structure and measurement invariance (2025 · BMC Public Health · 被引 10)
• Phase 2 study of relmacabtagene autoleucel (CD19 CAR-T) for relapsed/refractory mantle cell lymphoma in Chinese adults (2025 · Blood Advances · 被引 5)
• Association between gestational diabetes mellitus and risk of breast cancer: a systematic review and meta-analysis (2025 · Frontiers in Endocrinology · 被引 5)
• Talquetamab, a GPRC5D×CD3 bispecific antibody, in Chinese patients with relapsed/refractory multiple myeloma: efficacy and safety from the phase 1/2 MonumenTAL-1 study (2025 · Haematologica · 被引 4)